, Tracking Stock Market Picks
Enter Symbol:
Five Prime Therapeutics Inc. (FPRX) [hlAlert]

down 15.26 %

Five Prime Therapeutics Inc. (FPRX) rated Outperform with price target $48 by Oppenheimer

Posted on: Monday,  Oct 19, 2015  10:25 AM ET by Oppenheimer

Oppenheimer rated Outperform Five Prime Therapeutics Inc. (NASDAQ: FPRX) on 10/19/2015. Previously Oppenheimer rated Outperform Five Prime Therapeutics Inc. (NASDAQ: FPRX) on
05/15/2015., when the stock price was $22.14. Since then, Five Prime Therapeutics Inc. has lost 15.27% as of 01/22/2016's recent price of $18.76.
If you would have followed the previous Oppenheimer's recommendation on FPRX, you would have lost 15.26% of your investment in 252 days.

OppenheimerFunds, Inc. has been helping investors achieve their financial goals since 1960. We are one of the nation's largest and most respected asset management companies. At OppenheimerFunds, we believe that in order for you to reach your financial goals, your investments must perform. That is why investment excellence—over the long term and across the range of our products—is our highest priority. OppenheimerFunds and its controlled affiliates offer a broad range of products and services to individuals, corporations and institutions, including mutual funds, separately managed accounts, investment management for institutions, hedge fund products, qualified retirement plans and subadvisory investment-management services.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/19/2015 10:25 AM Buy
31.17 48.00
as of 8/27/2015
1 Week down  -6.99 %
1 Month down  -26.17 %
3 Months down  -11.38 %
1 YTD down  -15.26 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/15/2015 8:25 AM Buy
22.14 45.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy